Search research articles
Contact Us
Filters
Showing results (261-270 of 270) with videos related to
Page
of 27
Sort By:
You have reached the last page of results.
This site can display upto 270 results.
Bioorganic & Medicinal Chemistry Letters
|
July 28, 2020
Optimization of a series of potent, selective and orally bioavailable SYK inhibitors
Neil P Grimster, Lakshmaiah Gingipalli, Bernard Barlaam, et al.
Communications Biology
|
May 13, 2024
Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC
Thomas G Hayhow, Beth Williamson, Mandy Lawson, et al.
Journal of Medicinal Chemistry
|
February 6, 2020
Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRAS<sup>G12C</sup>
Jason G Kettle, Sharan K Bagal, Sue Bickerton, et al.
Journal of Medicinal Chemistry
|
April 26, 2022
Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRAS<sup>G12C</sup>
Jason G Kettle, Sharan K Bagal, Sue Bickerton, et al.
Schizophrenia Bulletin
|
May 9, 2026
Persistent Negative Symptoms: Characterization of an Unmet Need in a Learning Health System for First-Episode Psychosis
Deepak K Sarpal, Swati Nayar, Robert W Buchanan, et al.
Early Intervention in Psychiatry
|
April 2, 2025
Connection Learning Healthcare System Hub of the Early Psychosis Intervention Network: Program and Participant Characteristics
Monica E Calkins, Megan Jumper, Arielle Ered, et al.
Schizophrenia Research
|
March 28, 2024
Tobacco smoking and nicotine vaping in persons with first episode psychosis
Melanie E Bennett, Deborah Medoff, Tovah Cowan, et al.
Journal of Medicinal Chemistry
|
July 3, 2023
Discovery of AZD4747, a Potent and Selective Inhibitor of Mutant GTPase KRAS<sup>G12C</sup> with Demonstrable CNS Penetration
Jason G Kettle, Sharan K Bagal, Derek Barratt, et al.
Journal of Medicinal Chemistry
|
September 3, 2025
Discovery of AZD8421: A Potent CDK2 Inhibitor with Selectivity Against Other CDK Family Members and the Human Kinome
Avipsa Ghosh, Afshan Ahmed, Konstantina Amoiradaki, et al.
Journal of Medicinal Chemistry
|
February 10, 2025
Discovery and Optimization of Pyrazine Carboxamide AZ3246, a Selective HPK1 Inhibitor
Jason D Shields, David Baker, Amber Y S Balazs, et al.
Page
of 27
Search research articles
Search
Showing results (261-270 of 270) with videos related to
Sort By:
Page
of 27
You have reached the last page of results.
This site can display upto 270 results.
Bioorganic & Medicinal Chemistry Letters
|
July 28, 2020
Optimization of a series of potent, selective and orally bioavailable SYK inhibitors
Neil P Grimster, Lakshmaiah Gingipalli, Bernard Barlaam, et al.
Communications Biology
|
May 13, 2024
Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC
Thomas G Hayhow, Beth Williamson, Mandy Lawson, et al.
Journal of Medicinal Chemistry
|
February 6, 2020
Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRAS<sup>G12C</sup>
Jason G Kettle, Sharan K Bagal, Sue Bickerton, et al.
Journal of Medicinal Chemistry
|
April 26, 2022
Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRAS<sup>G12C</sup>
Jason G Kettle, Sharan K Bagal, Sue Bickerton, et al.
Schizophrenia Bulletin
|
May 9, 2026
Persistent Negative Symptoms: Characterization of an Unmet Need in a Learning Health System for First-Episode Psychosis
Deepak K Sarpal, Swati Nayar, Robert W Buchanan, et al.
Early Intervention in Psychiatry
|
April 2, 2025
Connection Learning Healthcare System Hub of the Early Psychosis Intervention Network: Program and Participant Characteristics
Monica E Calkins, Megan Jumper, Arielle Ered, et al.
Schizophrenia Research
|
March 28, 2024
Tobacco smoking and nicotine vaping in persons with first episode psychosis
Melanie E Bennett, Deborah Medoff, Tovah Cowan, et al.
Journal of Medicinal Chemistry
|
July 3, 2023
Discovery of AZD4747, a Potent and Selective Inhibitor of Mutant GTPase KRAS<sup>G12C</sup> with Demonstrable CNS Penetration
Jason G Kettle, Sharan K Bagal, Derek Barratt, et al.
Journal of Medicinal Chemistry
|
September 3, 2025
Discovery of AZD8421: A Potent CDK2 Inhibitor with Selectivity Against Other CDK Family Members and the Human Kinome
Avipsa Ghosh, Afshan Ahmed, Konstantina Amoiradaki, et al.
Journal of Medicinal Chemistry
|
February 10, 2025
Discovery and Optimization of Pyrazine Carboxamide AZ3246, a Selective HPK1 Inhibitor
Jason D Shields, David Baker, Amber Y S Balazs, et al.
Page
of 27